Digilant Cares

Making Strides for Men’s Health with Movember

12/12/2017 - Mitchell Carey

As a well-established tradition at Digilant, it’s not a surprise to anyone in our Boston office when the end of October comes around and many men take out their razors to get their last clean shave in before the Movember Foundation‘s annual fundraising campaign begins. For those unfamiliar with Movember, growing out your facial hair for an entire month may seem a bit odd, but their’s a mission behind the mustache.

The Movember Foundation was established in Melbourne Australia in 2003 by two friends, Travis and Luke, who wondered why the stache had gone out of style. Inspired by a friend’s mom who had been fundraising for breast cancer, the duo thought that they’d support a good cause while attempting to revive the grooming style. They recognized that there’s strength in numbers, so they launched an email campaign with the subject line, “Are you man enough to be my man?” and recruited 30 other men to grow out their mustaches. Needless to say, it was a very successful test campaign, as the movement has since galvanized over 5 million “Mo Bros” & “Mo Sistahs” across 21 countries to get involved with the cause.

This year Digilant Cares U.S. created a MoTeam to raise funds amongst friends, family, and colleagues. We’re proud to say that the team managed to exceed its goal this year and these donations have also been matched by Digilant’s holding company, ispDigital. In total, over a thousand dollars will be put forth towards tackling physical and mental health issues faced by men. In addition to prostate cancer, Movember now helps fund testicular cancer research and treatment, supports mental health programs and organizes suicide prevention initiatives.

If you’d like to help the Digilant Cares team in continuing to raise funds for men’s health, visit our MoTeam here, or donate your time through events near you.

https://www.youtube.com/watch?v=ABwsqypKNZI

Like what you see? Join the 500+ clients that have partnered with Digilant.